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Abstract
Background: Stromal-Derived Inducing Activity (SDIA) is one of the most efficient methods of generating dopaminergic
(DA) neurons from embryonic stem cells (ESC). DA neuron induction can be achieved by co-culturing ESC with the mouse
stromal cell lines PA6 or MS5. The molecular nature of this effect, which has been termed ‘‘SDIA’’ is so far unknown.
Recently, we found that factors secreted by PA6 cells provided lineage-specific instructions to induce DA differentiation of
human ESC (hESC).
Methodology/Principal Findings: In the present study, we compared PA6 cells to various cell lines lacking the SDIA effect,
and employed genome expression analysis to identify differentially-expressed signaling molecules. Among the factors
highly expressed by PA6 cells, and known to be associated with CNS development, were stromal cell-derived factor 1 (SDF-
1/CXCL12), pleiotrophin (PTN), insulin-like growth factor 2 (IGF2), and ephrin B1 (EFNB1). When these four factors, the
combination of which was termed SPIE, were applied to hESC, they induced differentiation to TH-positive neurons in vitro.
RT-PCR and western blot analysis confirmed the expression of midbrain specific markers, including engrailed 1, Nurr1, Pitx3,
and dopamine transporter (DAT) in cultures influenced by these four molecules. Electrophysiological recordings showed
that treatment of hESC with SPIE induced differentiation of neurons that were capable of generating action potentials and
forming functional synaptic connections.
Conclusions/Significance: The combination of SDF-1, PTN, IGF2, and EFNB1 mimics the DA phenotype-inducing property of
SDIA and was sufficient to promote differentiation of hESC to functional midbrain DA neurons. These findings provide a
method for differentiating hESC to form DA neurons, without a requirement for the use of animal-derived cell lines or
products.
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Introduction
There is a great interest in the possibility of using human
embryonic stem cells (hESC) to produce specific cell types which
might be used either in cellular therapy or as in vitro models of
human cells. Among the most interesting cell types that can be
derived from hESC are DA neurons, both because of their
potential use as a therapy for Parkinson’s disease (PD), and as in
vitro models for testing drugs relevant to neurodegenerative
disorders, drug abuse, and addiction.
A number of groups have reported on directing hESC to
differentiate into dopamine (DA) neurons [1–7]. The most
commonly-used technique for producing DA neurons from ESC
requires a co-culture step, most often using stromal cells such as
the mouse PA6 cell line, but in some cases human astrocytes or
other cell lines [8–18]. Often, patterning factors including SHH
and FGF8 are employed, but these factors are effective only
following an early induction step [19,20]. A second method
involves the formation of embryoid bodies (EBs), in which case
internal factors, produced by hESC, are presumably responsible
for the early induction phase. This approach involves a complex
series of procedures including enzymatic digestion and various
isolation techniques followed by SHH and FGF8 exposure [2,5].
The biochemical nature of the initial stage of differentiation is
unknown, and whether this activity is related to the SHH-FGF8
signaling system or the organizing stimulus remains to be
elucidated. Upon discovery of SDIA, it was suggested that this
activity accumulates on the surface of PA6 cells [8]. Other studies
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differentiation process [21,22]. In a recent study, we analyzed the
effects of PA6 cell surface activity and secreted factors separately,
and concluded that secreted factors are primarily responsible for
the DA-inducing effect, whereas cell surface activity enhanced cell
survival and overall neurogenesis [23].
In view of these findings, we carried out gene expression
profiling of PA6 cells to identify genes coding for soluble
factors with a potential role in the DA induction of hESC. In
order to select the most relevant set of molecules, we conducted
comparisons between the potent PA6 cell line and mouse
embryonic fibroblasts (MEF), a mouse kidney cell line MM55K,
and subtypes of PA6 and MS5 lines that lack DA-inducing activity.
For clarity, we will refer to the potent PA6 cell line as PA6-DA,
and PA6 subtypes as PA6-X1 and PA6-X for the remainder of this
paper. The transformation of the PA6-DA cells to the PA6-X cell
phenotype was an unpredictable event and unrelated to the
number of passages in culture. Once transformed to the PA6-X
phenotype, reversion to the PA6-DA morphological phenotype did
not occur. On the basis of the gene expression analysis, we selected
a set of candidate genes, including SDF-1, PTN, IGF2, Insulin-like
growth factor binding protein 4 (IGFBP4), and EFNB1, and
examined the role of molecules encoded by these genes in DA
induction of hESC in vitro. The four factors SDF-1, PTN, IGF2,
and EFNB1 were sufficient to induce hESC to differentiate to DA
neurons.
Materials and Methods
Cell lines
Mitotically-inactivated MEF feeder layers (Millipore, Billerica,
U. S. A.) were cultured in cell culture dishes coated with 0.1%
gelatin (Millipore) with high-glucose Dulbecco’s Modified Eagle’s
Medium (DMEM) (Invitrogen, Gaithersburg, U. S. A.), supple-
mented with 10% fetal bovine serum (Atlanta Biologicals,
Lawrenceville, U. S. A.) and 50 U/ml Penn-Strep. The
MM55K mouse kidney cell line was purchased from American
Type Culture Collection (ATCC, Manassas, U. S. A.) and
cultured with high-glucose DMEM containing 10% fetal bovine
serum and 50 U/ml Penn-Strep. The PA6 mouse stromal cell line
was obtained from Riken BioResource Center Cell Bank
(Tsukuba, J. P. N.). MS5 cells were kindly provided by Dr Caruz
(University of Jae ´n, E. S. P.). The stromal cell lines were cultured
in a–minimum essential medium (Invitrogen) supplemented with
10% fetal bovine serum and 50 U/ml Penn-Strep. Sub-culturing
of these cell lines was accomplished by trypsinization using 0.5–
1 ml 0.05% trypsin-EDTA (Invitrogen) for 2–3 min.
hESC lines used were: BG01V2, BG02, and BG03, derived by
BresaGen (Athens, U. S. A.). The BG01V2 hESC line is a variant
of the hESC line BG01 [24]. Mitotically-inactivated MEFs were
used as feeder cells to maintain BG01V2 in an undifferentiated
state. The hESC culture medium consisted of DMEM/nutrient
mixture (1:1), supplemented with 10% Knockout serum replace-
ment, 2 mM L-glutamine, 1 mM nonessential amino acids, 4 ng/
ml bFGF (Invitrogen), 50 U/ml Penn-Strep (Invitrogen), and
0.1 mM b-mercaptoethanol (Millipore). The culture media was
changed daily with routine passage of hESC on fresh MEF layers
carried out once a week. hESC colonies were isolated from the
MEF feeder layers with 1 mg/ml collagenase type IV (Invitrogen)
treatment for approximately 1 hr. Feeder-free cultures of BG01V2
were grown on human fibronectin, 20 mg/ml, (BD Biosciences,
Bedford, U. S. A.) in MEF conditioned medium (MEF-CM).
MEF-CM was collected daily, filtered and supplemented with an
additional 16 ng/ml of bFGF before feeding hESC. MEF cells
were used for 8–10 days for CM collection. CM that had been
frozen at 220uC for up to one month was also used.
Co-culture of BG01V2 with feeder cell lines
For co-culture experiments, the cell lines were grown to
confluence in 6-well tissue culture plates in their respective growth
media as previously described. Media was replaced with hESC
differentiation medium, comprised of Glasgow Minimum Essential
Medium(GMEM) supplemented with 10% knockout serum
replacement, 0.1 mM nonessential amino acids (Invitrogen),
1 mM sodium pyruvate (Sigma-Aldrich, St. Louis, U. S. A.), and
0.1 mM b-mercaptoethanol (Millipore). MEFs and stromal cells
were cultured in 0.1% gelatin and collagen type-I coated plates,
respectively. The PA6 subtype PA6-X exhibited rapid cell division
and a lack of contact inhibition of growth. Upon confluency, PA6-
X feeder layers retracted and detached from the plates. To avoid
detachment, cells were inactivated with 10 mg/ml mitomycin-c
(Sigma) for one hr followed by three washes with fresh medium
and permitted to recover overnight. BG01V2 colonies were
dissociated from the MEF feeder layer by enzymatic treatment
and added to the feeders at a density of 50–100 small colonies/well
corresponding to 5000–10000 cells/cm
2. The culture medium was
changed on day four and every other day thereafter. The hESC
were allowed to grow and differentiate on the feeder layers for 12
days.
Immunocytochemistry
Cultures were fixed in 4% paraformaldehyde in PBS and then
incubated with the primary antibodies in blocking buffer (PBS
containing 5% goat serum, 2% BSA, and 0.2% Triton X-100) at
room temperature for two hr.
The following primary antibodies were used: mouse anti-Oct 3/4
(1:50; Santa Cruz Biotechnology Inc., Santa Cruz, U. S. A.), rabbit
anti-TH (1:1000; Pel-Freez), mouse anti-TH (1:1000; Millipore),
rabbit anti–b III-tubulin (1:2000; Promega, Madison, U. S. A.),
mouse anti-nestin (1:50; R&D Systems Inc., Minneapolis, U. S. A.),
rabbitanti-GFAP(1:2000;Dako,Carpinteria,U.S. A.),mouseanti-
MAP-2 (1:500, BD Biosciences), and rabbit anti-MAP-2 (1:1000;
Millipore). Cultures were incubated with fluorescent-labeled
secondary antibodies [Alexa 488 (green) or Alexa 568 (red)-labeled
goatIgG;1:1000;MolecularProbe]inPBSwith1%BSAfor1 hrat
room temperature. The cells were rinsed three times for 5 min in
PBS. Negative controls included substituting the primary antibodies
with non-immune mouse and rabbit IgG (1:100; Santa Cruz) and
pre-absorption of the Oct3/4 primary antibody with its antigenic
peptide (0.2 mg/ml of N-terminal Oct3/4 of human origin; Santa
Cruz). To ensure the specificity of the polyclonal TH antibody, a
monoclonal anti-TH antibody recognizing an epitope in the N-
terminus (1:100; Sigma) was used. Cell morphology and intracel-
lular localization were carefully examined to confirm expression of
markers b-III-tubulin, MAP2, GFAP, and nestin. Images were
obtained using a Carl Zeiss Axiovert 200 M microscope (Thorn-
wood, New York, U. S. A.).
Statistical significance of the overall differences in numbers of
colonies expressing various markers among the experimental
groups was tested by analysis of variance (ANOVA) followed by
Tukey-Kramer multiple comparisons (GraphPad Software Inc.,
San Diego, U. S. A.). Differences were considered significant at
p,0.05.
RNA extraction and expression microarrays
For total RNA extraction, about 5610
6 cells from each of the
five cell lines were seeded onto 100 mm dishes. After 2 days, the
cells were washed two times with PBS, collected by scraping, and
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was used to isolate the RNA following manufacturer’s instructions.
RNAs derived from all the feeder cell lines were reverse-
transcribed, labeled, and analyzed using the Illumina microarray
platform (Sentrix Mouse-8 Expression BeadChip). Arrays were
processed according to the manufacturer’s instructions.
Microarray data analysis
Z-score transformation was used to compare gene expression
levels between the six cell lines independent of the original
hybridization intensities [25]. To obtain fold-like change in gene
expression, Z-scores were converted to Z-ratios and used for
statistical analysis to select differentially-expressed genes. Statisti-
cally significant differences were based on Z-ratio changes of at
least 3.0 and p,0.05.
Functional information in relation to the gene products and
gene expression patterns were obtained from the literature or from
the following databases: OMIM (http://www.ncbi.nlm.nih.gov/
sites/entrez?db=omim), Source (http://genome-www5.stanford.
edu/cgi-bin/source/sourceBatchSearch), Cell Migration Consor-
tium (http://cmckb.cellmigration.org), and Allen Brain Atlas
(ABA) (http://www.brain-map.org).
Significantly altered genes (Z-ratio$3.0) were categorized using
the platform gene ontology FatiGO (Fast Assignment and
Transference of Information using Gene Ontology, http://www.
fatigo.org) with respect to gene function including biological
process and molecular function [26].
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Mouse feeder cell lines. Complementary DNA for the
polymerase chain reaction (PCR) was reverse transcribed from
total RNA isolated from each feeder cell line. cDNA was
synthesized from 2 mg RNA using an oligo dT primer and 1 mL
MMLV (Promega, reverse transcription kit) in a 24-ml reaction
according to the manufacturer’s recommendations. The cycling
parameters were as follows: 65uC, 2 min; 42uC, 60 min; 72uC,
10 min. 100 units of MMLV-RT was added 10 min after the
reaction was brought to 42uC. The PCR reaction components for
detection of the candidate genes were as follows, 1 mL cDNA in
50 mL of PCR mix containing 56 PCR buffer, 5 mLo f1 5m M
MgCl2, 2 mL of 10 mM deoxyribonucleoside triphosphate
(dNTP), 0.5 mL each of 100 mM primers, and 5 units of GoTaq
DNA polymerase (all from Promega). The thermal cycling
parameters were as follows: primary denaturation, three minutes
at 94uC; 35 cycles of denaturation for 1 min at 94uC; annealing
for 1 min at 55uC; extension for 1 min at 72uC and final extension
for 7 min at 72uC.
Equal amounts of RNA were tested in PCR reactions under the
same conditions to ensure that the RNA samples were not
contaminated by genomic DNA. The housekeeping gene,
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was am-
plified as an internal control in gene expression analysis.
Primer sequences were obtained from the PrimerBank website
(http://pga.mgh.harvard.edu/primerbank/) and synthesized by
Invitrogen. The primer sequences can be found in Table S1.
Differentiated hESC. Total RNA was isolated from
BG01V2-derived EBs cultured in the presence or absence of
SPIE after 17 days of differentiation using RNA STAT-60 kit (Tel-
test Inc). RT-PCR was performed using a One –Step RT-PCR kit
(Clontech, Mountain View, U. S. A.) according to the
manufacturer’s instructions. DNase was added to the RNA
samples before RT-PCR. For each RT-PCR reaction, 1 ml
containing 500 ng of RNA was used in a 20 ml reaction volume.
The cycling parameters were 50uC for 1 hr; 94uC for 5 min, then
94uC 30 sec; 65uC 30 sec; 68uC 1 min, for 35 cycles and followed
by a final extension of 5 minutes at 68uC. GAPDH was used as
internal control. The primer sequences are listed in Table S1.
Functional analysis of candidate molecules
Colonies of hESC in feeder-free conditions were removed from
the tissue culture plates using a sterile cell scraper and partially
dissociated by gentle pipetting. The cell clusters were resuspended
in hESC culture medium without bFGF and transferred to ultra
low-attachment plates (Corning Incorporated) for EB formation.
The medium was changed every day. After 2–4 days, the EBs were
transferred to plates precoated with poly-L-ornithine (100 mg/ml,
Sigma), and then laminin (20 mg/ml, Invitrogen) and cultured in
hESC medium in the presence of heparin (100 mg/ml, Sigma) and
the various factors. The following final concentrations of the
selected growth factors were used: SDF-1 (100 ng/ml), PTN
(100 ng/ml), IGF2 (100 ng/ml), IGFBP4 (500 ng/ml), and
EFNB1 (200 ng/ml); all from R&D Systems. Half of the medium
was replaced with fresh medium containing growth factors on day
four and every two or three days after that. The cells were allowed
to differentiate under these conditions for 10–14 days.
Protein extraction and Western blot analysis
Proteins extracted from BG01V2-derived cultures treated with
SPIE, and cultures grown in the absence of SPIE, were used for
Western blot analysis. Briefly, cells were washed in PBS and lysed
in cold preparation of modified radioimmunoprecipitation buffer
(Millipore) and treated with protease inhibitors, phenylmethylsul-
fonyl fluoride (1 mM), leupeptin (1 mg/ml), and aprotinin
(2.5 KU). The lysates were sonicated for 10 s on ice and stored
at 280uC.
Twenty micrograms of protein was separated on a 4–12% Bis-
Tris, or 3–8% Tris-acetate gel (Invitrogen) and transferred at 4uC
to a PVDF-FL membrane overnight. After transfer, the membrane
was blocked in PBS containing 5% dried milk for one hr at room
temperature. The membrane was washed three times with PBST
for 15 min and incubated with primary antibodies in PBST
solutions containing 1% milk overnight at 4uC. The primary
antibodies used were rabbit anti-MAP2 (1:2000; Millipore), rabbit
anti-Nurr1 (1:1000; Millipore). Mouse anti-actin antibody (1:1000;
Santa Cruz) was used as an internal loading control. The
membrane was washed three times with PBST for 15 min, and
then incubated for 1 hr at room temperature with IRDye 700 and
IRDye 800 secondary antibodies (LI-COR Biosciences, Lincoln,
U. S. A.). After extensive washing, the blots were analyzed using
the LI-COR Odyssey infrared imaging system (Biosciences).
Electrophysiological recordings
The bathing solution was prepared to be similar in ionic
composition and identical in osmolarity to the DMEM/F12 culture
medium that the cells were grown in. It consisted of (mM): NaCl,
150; KCl, 4; MgCl2, 1; CaCl2, 1; NaH2PO4, 0.5; HEPES (hemi-
sodium), 10; glucose, 18; sucrose, 24, pH 7.4, 348 mOsm. The
pipette solution consisted of (mM): KCl, 140; MgCl2, 2, EGTA,11;
CaCl2, 1, HEPES, 10, pH 7.2. To this was added 4 mM of lucifer
yellow CH (dipotassium). Stock solutions of GABA, acetylcholine,
and glutamic acid were diluted 1:1000 on the day of use, and were
applied by superfusion from a Y-tube [27].
Cells were recorded by conventional whole cell recording using
an Alembic VE-2 amplifier (Alembic Instruments, Montreal, C. A.
N.) operating at 100% series resistance compensation. Recordings
were under the control of Pclamp v.7.0 (Molecular Devices,
Sunnyvale, U. S. A.). In the search for h-currents, cells were held
at 260 mV and stepped to 2100 mV for one second, then back to
Dopaminergic Induction of hESC
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recordings, the holding potential was 270 mV. Current-voltage
curves were obtained by stepping the voltage from the holding
potential to voltages of 280 to +50 mV in 10 mV increments. P/
N leak subtraction (8 substeps) was used for all voltage step
recordings. Current signals were filtered at 5 kHz and sampled at
25 kHz. Voltage signals were filtered at 2 kHz and sampled at
5 kHz.
Results
Assessment of dopaminergic inducing effect of feeder
cells
In order to test the abilities of MEF, MM55K, MS5, PA6-X1,
PA6-X and PA6-DA cell lines to induce DA induction of hESC,
small colonies of BG01V2 were co-cultured with each of the feeder
cell lines for 12 days. Undifferentiated stem cells were monitored
by examining expression of Oct3/4 after 12 days (Fig. 1A,D,G).
Percentages of Oct3/4+ colonies grown on MEF feeders and
MM55K cells were 58618% and 8268% respectively (Fig. 1A,D)
as compared to 82610% colonies expressing Oct3/4+ in co-
culture with the PA6-DA cells (Fig. 1G).
After 12 days, the majority of colonies grown on MEF, MM55K
or PA6-DA cells contained cells expressing the immature neuroep-
ithelial cell marker, nestin (Fig. 1B,E,H). Less than 1% of colonies
cultured on MEF and MM55K contained cells immunoreactive for
the DA neuronal marker TH (Fig. 1C,F). In contrast, 78613% of
colonies cultured on PA6-DA cells contained large numbers of TH+
neurons (Fig. 1I). Neurons expressing b-III-tubulin were detected in
565% and 363% of colonies grown on MEF and MM55K
respectively, whereas co-culture with PA6-DA cells resulted in
82613% b-III-tubulin+ colonies. The average percentages of Oct3/
4, nestin, b-III-tubulin and TH expressing colonies cultured on
MEF, MM55K and PA6-DA cells are presented as bar graphs in
Figure 1J. The cell lines PA6-X1, PA6-X, and MS5 were unable to
support the survival of hESC for 12 days. Therefore, we were not
able to assess differentiation of hESC in co-culture with these three
cell lines. MS5 cells, like PA6, are stromal cells and have been
reported to promote midbrain-specific neural precursor differenti-
ation [9,10]. The MS5 cells used in this study were most likely a
subtype of the original MS5 cell line, as they did not support DA
differentiation. Additional information can be found at ftp://137.
187.144.38/freed in the folder entitled ‘‘PA6 cell transformation’’.
Analysis of gene expression
By comparing gene expression of the PA6-DA cell line to the
five cell lines lacking SDIA, we identified a set of candidate genes
as potential DA-inducing elements. A complete gene list
containing Z-ratios can be found in the supplemental data at
ftp://137.187.144.38/freed. In total, 288 genes were preferential-
Figure 1. Marker expression analysis of differentiating hESC in co-cultures. BG01V2 colonies co-cultured with MEF (A–C), MM55K (D–F),
and PA6-DA (G-I) for 12 days. Expression of the stem cell marker Oct3/4 was detected in more than half of the colonies grown of MEF (A), while 82%
of colonies cultured on MM55K (D) and PA6-DA (G) contained Oct3/4+ cells. The early neuronal marker nestin was expressed in the majority of
colonies in co-culture with MEF (B), MM55K (E), and PA6-DA (H) cells. The presence of dopaminergic neurons, identified by expression of TH, was
found in 2% of colonies in MEF co-cultures (C) and in less than 1% of colonies grown on MM55K cells (F). The majority of colonies cultured on PA6-DA
contained large numbers of TH+ neurons (I). Quantification of percentages of colonies expressing Oct3/4, Nestin, b-III-tubulin and TH after 12 days of
co-culture on MEF, MM55K or PA6-DA feeder cells are presented as bar graphs with error bars indicating standard deviations. Data represent 60
colonies from three independent experiments (J). The overall difference in TH and b-III- tubulin expressing colonies was statistically significant in
conditions with MEF and MM55K cells (P,0.0001), as compared to PA6-DA co-cultures. Scale bar=200 mm.
doi:10.1371/journal.pone.0006606.g001
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PA6-X cell subtype. The majority of these genes were also
significantly up-regulated in PA6-DA cells as compared to the
transformed stromal cell lines, PA6-X1, MS5, and the MM55K
and MEF cells. Biological processes were available for 159 of the
288 genes analyzed using the FatiGO web tool. The functions of
these genes included 50 different categories at the most basic level.
In order to identify genes involved in biological processes and
pathways related to CNS development among the 288 up-regulated
genes, we performed a more advanced gene ontology analysis using
the FatiGO web tool at specificity level six, as illustrated in Table 1.
By focusing on soluble secretory molecules and gene products with a
possible role in CNS development and regulation of neurogenesis, we
identified stromal cell-derived factor 1 (SDF-1/CXCL12), pleiotro-
phin (PTN), insulin-like growth factor 2 (IGF2), insulin-like growth
factor binding protein 4 (IGFBP4), and ephrin B1 (EFNB1) as factors
potentially responsible for DA inducing activity. This combination of
factors was termed ‘‘SPIE’’, as it was eventually determined that
IGFBP4 was unnecessary (see below). These genes were among the
most up-regulated in PA6-DA cells as compared to PA6-X or
MM55K cells, each having a seven-fold or greater Z-ratio. Relative
expression ofthese genes in PA6-DA versus each cell type is presented
in Table 2. Differences in these transcripts as determined by RT-
PCR were strongly correlated with the microarray results (Fig. 2).
As shown in Table 1, the selected genes SDF-1(CXCL12) and
EFNB1 were included in the CNS and neuronal development
Table 1. Gene clusters highly expressed in PA6-DA cells.
Gene Ontology Biological Process at Level 6 Gene UniGene Accession Percentage of Genes Z-ratios
PA6-DA MM55K
Neurogenesis IDB4 NM_031166.1 5.88 3.16 2.57
EFNB1 NM_010110.2 8.56 7.43
CXCL12 NM_013655.2 16.27 14.34
TIMP2 NM_011594.2 3.32 1.66
MYH10 NM_009382.2 9.62 5.18
THY1 NM_175260.1 3.15 2.90
RUNX1 NM_009821.1 4.28 4.71
NOTCH1 NM_008714.2 3.02 3.99
Central nervous system development OTX1 NM_011023.2 3.68 3.22 2.04
IDB4 NM_031166.1 3.16 2.57
CXCL12 NM_013655.2 16.27 14.34
MYH10 NM_175260.1 3.15 2.90
NOTCH1 NM_008714.2 3.02 3.99
Tissue development MGLAP NM_008597.2 3.68 9.42 1.40
PTN NM_008973.1 13.50 14.60
SOX9 NM_011448 11.62 6.33
OTOR NM_020595 4.04 4.61
NOTCH1 NM_008714.2 3.02 3.99
Wnt receptor signaling pathway SFRP1 NM_013834.1 2.94 14.24 14.53
SFRP2 NM_009144.1 3.16 3.09
FRZB NM_011356.2 3.44 2.56
PPAP2B NM_080555.1 3.37 7.36
Cellular morphogenesis during differentiation EFNB1 NM_010110.2 2.94 8.56 7.43
CXCL12 NM_013655.2 16.23 14.34
THY1 NM_009382.2 9.62 5.18
NOTCH1 NM_008714.2 3.02 3.99
Neural crest cell differentiation EFNB1 NM_010110.2 2.21 8.56 7.43
SEMA3F NM_011349.2 4.66 0.40
SOX9 NM_011448 11.62 6.33
Regulation of cell migration CXCL12 NM_013655.2 2.21 16.23 14.34
THY1 NM_009382.2 9.62 5.18
Cell fate specification SOX9 NM_011448 2.21 11.62 6.33
NOTCH1 NM_008714.2 3.02 3.99
Neural tube development LTAP NM_033509.2 0.74 3.21 2.18
Gene clusters categorized into biological processes at level six with relevance to various aspects of brain development and maintenance of central neurological
processes. Expression levels of genes in PA6-DA as compared to PA6-X and MM55K cells are presented as Z-ratios.
doi:10.1371/journal.pone.0006606.t001
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cluster by FatiGO. IGF2 and IGFBP4 were not included in
categories related to neural development, but were assigned to
organ morphogenesis and cell growth. In addition, PTN,
Fibroblast growth factor-10 (FGF10), and serpin peptidase
inhibitor, clade E (SERPINE2) also known as glial-derived neurite
promoting factor, were classified as heparin binding factors by
gene ontology in molecular function at level six. SERPINE2 and
FGF10 were highly expressed in PA6-DA cells, with Z-ratios of
approximately three and 14 respectively, as compared to both
PA6-X and MM55K cells (Table S2).
In vitro functional analysis of candidate molecules
To examine whether the selected molecules were directly
responsible for SDIA, we initially used a previously established
protocol [23] which was used to test the effects of PA6 cell
conditioned medium. Undifferentiated hESC were simply trans-
ferred to hESC differentiation medium containing the five factors.
Under these conditions, the majority of isolated hESC did not
survive well or form colonies. To enhance cell survival, we
generated EBs from hESC which were maintained in feeder-free
conditions, after which the differentiation medium was replaced
with hESC growth medium lacking the mitogen bFGF. After two-
four days, resultant EBs were transferred to poly-L ornithine/
laminin coated dishes and were allowed to differentiate in the
presence of heparin and selected molecules.
When hESC maintained in feeder-free conditions were cultured
in hESC medium lacking bFGF, but with omission of the EB step,
they survived well, but SPIE induced minimal DA differentiation
(data not shown).
The majority of EBs exposed to the selected factors in hESC
culture mediumformed radial glia scaffolds(Fig. 3A), and developed
into cells in columnar arrangements after three days in culture
(Fig. 3B). In contrast, less than 50% of EBs cultured in the hESC
medium alone, in the presence of heparin, attached to the culture
dishes.Inaddition,underthelatter conditiontherewasa substantial
decrease in cell viability (Fig. 3C,D). To determine whether the
cultures induced by these factors contained mesencephalic-restrict-
ed neural progenitor cells or DA neurons, analysis of Msx1 and TH
expression was carried out after 10 days. The majority of colonies
contained numerous TH+ neurons (Fig. 3E, F), predominantly
found in the periphery of colonies. Cells in the central, denser areas
of colonies were relatively undifferentiated at this time, as illustrated
by expression of the midbrain progenitor marker Msx1 (Fig. 3G).
TH was detected in the majority of b-III-tubulin-expressing cells
(Fig. 3H). To further characterize the role of the five candidate
molecules in TH+ cell induction, EB cultures were exposed to
various combinations of inducing factors followed by immunocy-
tochemical marker analysis after 10 days of differentiation. The
results indicated that IGF2 enhanced survival of the proliferating
NPC. In contrast, IGFBP4 reduced survival of the differentiating
hESC, possibly by inhibiting IGF2 (data not shown).
The combination of SDF-1, PTN, IGF2, and EFNB1 was more
efficient than the combination of five factors including IGFBP4.
The combination of the four factors SDF-1, PTN, IGF2, and
EFNB1 was therefore termed ‘‘SPIE’’. The absence of any one
Table 2. Relative expression of the five candidate genes.
Genes UniGene Accession Z-ratios
PA6-DA/PA6-X PA6-DA/PA6-X1 PA6-DA/MS5 PA6-DA/MM55K PA6-DA/MEF
CXCL12 NM 013655.2 16.27 16.92 15.08 14.34 9.96
EFNB1 NM 010110.2 8.56 9.26 8.40 7.43 7.01
PTN NM 008973.1 13.50 14.58 12.17 14.60 5.70
IGF-II NM 010514.1 13.19 13.83 11.63 13.52 3.28
IGFBP4 NM 010517.2 14.18 13.39 12.70 12.50 5.73
Gene expression in the PA6-DA cell line versus the cell lines PA6-X, PA6-X1, MS5, MM55K, and MEF, shown as Z-ratios.
doi:10.1371/journal.pone.0006606.t002
Figure 2. Confirmation of microarray results by RT-PCR. cDNA of
PA6-DA, PA6-X and MM55K cell lines were analyzed by RT-PCR using
gene specific primers for the five candidate genes selected from the
microarray data. RT-PCR analysis reproduced the results of cDNA
microarray for all five genes, including SDF-1, IGF2, IGFBP4, PTN, and
EFNB1. Amplification was performed for 35 cycles. GAPDH was
amplified simultaneously as an internal control under the same
conditions.
doi:10.1371/journal.pone.0006606.g002
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differentiation, as compared to cultures exposed to complete SPIE
(Fig. 3I). Omission of SDF-1 or EFNB1 decreased the number of
TH+ colonies by more than 50%. Cultures lacking PTN or IGF2
contained approximately 33% and 41% less TH expressing
colonies respectively. Exclusion of SDF-1 or EFNB1 also had the
largest effect on generation of midbrain NPC as indicated by 86%
and 85% decrease in Msx1+ colonies, respectively, as compared to
treatment with all four factors (Fig. 3I). Exclusion of PTN or IGF2
decreased the percentage of colonies containing Msx1-expressing
cells from 48%, to 17% and 10%, respectively. In addition,
numbers of TH+ cells within colonies were greatly decreased in
conditions lacking any one of the factors (Fig. 3J).
To determine whether the synergistic action of the candidate
molecules represents a general mechanism for the induction of DA
neurons from hESC, we extended our analyses to two other hESC
lines, BG02 and BG03, with normal karyotypes. EBs derived from
the BG02 line were tested with all five factors, and showed overall
poor survival. Colonies of differentiating BG02 cells in the presence
of selected factors showed somewhat enhanced survival, and cells
with a neuronal morphology were found within these colonies three
days after EBs were transferred to adherent cultures (Fig. 4A).
Figure 3. Differentiation of EBs into TH+ neurons induced by candidate molecules. Following EB formation, the hESC were transferred to
poly-L-ornithine/laminin coated dishes and treated with SDF-1, IGF2, IGFBP4, PTN, EFNB1, and heparin. After three days, EBs attached to the plates
and differentiated into neuroectodermal cells arranged in rosette-like structures with neuronal morphology (A, B). In contrast, the majority of EBs
cultured in medium containing heparin in the absence of these molecules did not adhere. The few colonies that did attach in this condition exhibited
exceedingly poor cell survival (C, D). After an additional seven days, the majority of colonies contained high percentages of TH+ neurons (E, F),
although the center of colonies remained in a relatively undifferentiated state with expression of Msx1 (G). b-III-tubulin and TH co-labeling also
revealed TH expression in the majority of neuronal cells (H). Scale bars=200 mm. (I) Percentages of colonies expressing TH and Msx1 after 10 days
under the influence of various combinations of the four factors, SDF-1(S), PTN (P), IGF2 (I), and EFNB1 (E). For numbers of TH-expressing colonies, each
of the various combinations of three of the four factors was significantly different from both SPIE-treated and untreated cultures (all p,0.001 except
untreated vs. SDF1 which was p,0.05 and SPIE vs. PTN which was p,0.01). Each of the combinations of three factors produced significantly fewer
Msx1-positive colonies than did treatment with complete SPIE (all p,0.001). The percentage of Msx1-expressing colonies was significantly greater
than the untreated condition only for the treatment with all four factors (SPIE) and for the condition excluding IGF2. *=P,0.05, **=P,0.01, and
***=P,0.001 as compared to the untreated condition (Tukey-Kramer multiple comparisons following one-way analysis of variance). (J) Examples of
colonies with omission of each individual factor, illustrating that fewer TH+ cells were detected within colonies, although numbers of TH+ cells within
colonies could not be quantified.
doi:10.1371/journal.pone.0006606.g003
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the molecules primarily had an epithelial morphology and did not
contain cells with recognizable neuronal appearance (Fig. 4B). After
five days of differentiation, TH+ neurons were found in treated
cultures (Fig. 4C, D), but were completely absent from the untreated
condition. Of note, expression of Msx1 was not found in either in
the treated or the control condition for BG02 cells.
In contrast to BG02 cells, EBs derived from the BG03 cell line
survived well either in the presence or absence of SPIE. The
BG03-derived EBs that were exposed to SPIE differentiated into
rosettes (Fig. 4E), morphologically similar to those seen in SDIA-
induced BG01V2 cultures. In contrast, colonies in the untreated
cultures had a more uniform appearance and fewer rosettes were
seen in these cultures (Fig. 4F). When these EBs were allowed to
differentiate for 10 days, more that 90% of colonies were Msx1+
with extensive networks of TH+ neuronal cells (Fig. 4G). Also, the
majority of cells within colonies were Msx1+ (Fig. 4H)
RT-PCR and immunoblot analysis of SPIE-treated cultures
Expression of markers involved in midbrain DA neuron
development were assessed by RT-PCR in SPIE-treated and
untreated cultures after 17 days of culture (Fig. 5A). LIM
Figure 4. Effect of candidate molecules on differentiation of the BG02 and BG03 lines. Differentiation of EBs derived from the BG02 (A–D)
and BG03 (E–H) hESC lines. Phase contrast images of (A) BG02-derived EBs differentiated in the presence of the candidate signaling molecules, SDF-1,
IGF2, IGFBP4, PTN, EFNB1, or (B) in the absence of any factors, three days after seeding on adherent cultures. After 10 days of culture, TH-
immunoreactive neurons were found in cultures treated with the five candidate molecules (C, D), and completely absent in the untreated cultures.
Images of EBs generated from the BG03 cell line differentiating in the presence of candidate factors (E), or in cultures that did not contain any of the
five molecules (F). (G, H) Expression of Msx1 and TH in BG03-derived cultures after 10 days of treatment with the selected factors, illustrating
expression of Msx1 in the majority of cells within colonies. Scale bars=200 mm.
doi:10.1371/journal.pone.0006606.g004
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the dopamine synthetic pathway, TH and aromatic L-amino acid
decarboxylase (AADC), were detected at substantially higher levels
in cultures influenced by SPIE, as compared to randomly-
differentiated cultures. Midbrain specific paired-like homeodo-
main transcription factor 3 (Pitx3) and engrailed 1 (En1) were
expressed in SPIE-treated cultures, but not detected in untreated
cultures. Expression of receptors GFR1 and c-RET for glial cell
line-derived neurotrophic factor, was upregulated by SPIE.
Increased expression of the brain-derived neurotrophic factor
receptor, TrkB, and the smoothened (SMO) receptor was also
confirmed in SPIE treated cultures. Neurons generated in the
presence of SPIE also expressed the dopamine transporter (DAT)
which is exclusively found in midbrain DA neurons.
Western blot analysis confirmed expression of the MAP2,
Nuclear receptor 1 (Nurr1), and TH proteins (Fig. 5B). In
agreement with previously obtained immunostaining data, TH
and MAP2 levels were increased by SPIE treatment. Nurr1 was
also detected in untreated cultures, but was increased by SPIE.
The Pitx3 antibody detected a band at the expected molecular
weight (42 kDa), which was increased in the SPIE-treated cultures
(Fig. 5B). In addition, the Pitx3 antibody detected non-specific or
unknown bands at approximately 95 and 145 kDa, and these
bands were not increased by SPIE (data not shown).
Electrophysiological studies
After 21 days of differentiation, about 80% of colonies contained
numerous TH+ neurons (Fig. 6A). Cell counting revealed that
45612% of the total number of cells were neurons, as determined
by expression of the mature neuronal marker MAP2. Double
staining showed co-localization of TH in 7168% of MAP2+
neurons(Fig.6B).Wecarefullyassessed the cell morphologyofTH+
cells which showed a fusiform shape typical of DA neurons [28]
(Fig. 6C), and selected neurons with this morphological phenotype
for electrophysiological recordings after 14, 16, 18, and 21 days of
differentiation. The fraction of excitable cells, as measured by
voltage gated sodium and potassium currents, and the fraction of
cells showing sensitivity to the neurotransmitters GABA, and
glutamate showed progressive changes (Fig. 6D).
The maximum current values for potassium (Fig. 6E) and
sodium (Fig. 6F) generally had a bimodal (log-normal) distribution.
For both currents, the fraction of the smaller mode shrank with
time while the amplitude of the larger mode remained fairly
constant. The GABA-induced currents also showed progressive
increases with time (Fig. 6G). By contrast, 64 to 81% of the cells
showed no response to acetylcholine (ACh), and this percentage
showed no clear change with time. Even in responsive cells, the
ACh-evoked currents were generally small (,20 pA). Currents
elicited by glutamate showed a tendency to increase with time in
culture, but evidence of a time-dependent trend was weak. In
concert with the relatively large voltage gated currents was the
appearance of single (Fig. 6H) and occasionally multiple action
potentials (Fig. 6I) in current clamp mode. The increase in the
percentage of cells that generated action potentials over time is
illustrated in Figure 6D. None of the cells showed a hyperpolar-
ization-activated h-current characteristic of dopamine neurons.
After 21 days of differentiation, spontaneous synaptic currents
were detected (Fig. 6J).
Figure 5. RT-PCR and western blot analysis of SPIE treated cultures. (A) Comparative RT-PCR results showing the effect of SPIE treatment on
differentiation of BG01V2 cells to midbrain-specific DA neurons after 17 days, as confirmed by increased expression of TH, AADC, Lmx1b, Pitx3, En1,
DAT and receptors including GFR1, TrkB, SMO, and c-RET. GAPDH was amplified under the same conditions (35 cycles) as an internal control. (B)
Western blot analysis illustrating the increased levels of MAP2, Pitx3, Nurr1 and TH proteins, as compared to untreated cultures. The housekeeping
gene actin shown in the lower panel was used as an internal loading control.
doi:10.1371/journal.pone.0006606.g005
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time course of these currents, indicating that they were
spontaneous, miniature postsynaptic currents. The small ampli-
tudes (22.668.4 pA) and brief decays (0.9360.15 ms) imply that
these currents were mediated by glutamate.
Discussion
Over the past several years, there have been an increasing
number of studies describing generation of DA neurons from
mouse, primate and hESC [1–17]. These approaches, in most
cases, involve co-culture systems using various feeder cells
mediating neural and DA inductive signaling. Currently, the cell
population with the greatest ability to support DA neuron
differentiation is the mouse bone marrow-derived PA6 stromal
cell line [8–13,18,23]. Alternatively, protocols for the enrichment
of DA neurons from human and mouse ES cells without feeder
cells require generation of retinoic acid treated EBs followed by
exposure to midbrain specification factors such as SHH and FGF8
[2,5,18,19].
Recently, transplantation of SDIA-derived neurons from
monkey ESC was reported to result in an improvement in
parkinsonian symptoms in a primate animal model [13]. Although
such findings are encouraging, for clinical translation all cell-based
therapeutic agents would need to be free of animal-derived cells or
materials because of concerns about possible transfer of pathogens
or xenogens, which may trigger immune reactions in human
subjects.
When SDIA was identified by Kawasaki and coworkers [8], it
was proposed that this activity accumulated on the cell surface.
Figure 6. Electrophysiological analysis BG01V2-derived cultures differentiated by SPIE. Representative images of TH (A), and TH and
MAP2 (B) immunocytochemistry of cultures differentiated for 21 days by SPIE (Scale bar 200 mm). Illustration of the cellular morphology of TH-
immunoreactive neurons (C). Bar graph showing percentages of cells eliciting sodium (INA), potassium (IK), GABA-evoked (IGABA), and Glutamate-
evoked (IGlu) currents and percentage of cells capable of generating action potentials (AP) after 14 (blue), 16 (red), 18 (black) and 21 (green) days.
Representation of cumulative log-normal distribution of maximum potassium currents (E), sodium currents (F), and GABA currents (G) over time.
Hoffman modulation contrast image of a cells showing electrical excitability as indicated by strong inward sodium currents (red curve) and outward
potassium currents (blue curve) under voltage clamp at day 21 of differentiation (H). In current clamp mode, this cell exhibited a strong AP which was
obtained by a 90 pA current step from a membrane potential of 2112 mV with an after hyperpolarization (H). An example of a neuron capable of
generating multiple APs after 18 days of differentiation (I). Spontaneous, miniature postsynaptic currents recorded from a cell at day 21 of
differentiation (J).
doi:10.1371/journal.pone.0006606.g006
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inducing factors, significant induction of differentiation could not
be achieved by PA6-conditioned medium alone [8]. In searching
for possible mechanisms, this group and others have looked at
BMP and Wnt signaling effects on neural differentiation [8,29],
but it has so far not been possible to reproduce the SDIA effect in
the absence of PA6 cells. Previously we reported that the SDIA
effect of PA6 cells resided in secreted factors, because conditioned
medium had a clear DA-inducing effect in the presence of
heparin.[23].
To better understand the molecular basis of SDIA, in the
current study we compared gene expression array data sets
developed by profiling different cell lines, including the potent PA6
line, to identify genes potentially responsible for early DA
induction of hESC. We selected a combination of five transcripts
that were highly expressed in the PA6-DA cells, including SDF-1,
PTN IGF2, IGFBP4, and EFNB1, as potential DA-promoting
elements. In the presence of these molecules, the majority of
hESC-derived EBs differentiated into Msx1+ mesencephalic
neural progenitor cells and TH+ neurons after 10–14 days, clearly
mimicking the SDIA effect.
Application of the selected molecules to EBs derived from two
karyotypically normal hESC lines, BG02 and BG03, provided
further evidence that these compounds were indeed capable of
initiating the process of DA differentiation. Although the three
hESC lines tested with the selected factors, BG01V2, BG02, and
BG03, showed substantial differences in their baseline degree of
differentiation in the absence of the molecules, TH expression was
consistently increased by SPIE treatment in all three lines.
Importantly, the cellular morphology of the TH+ cells generated
by SPIE (Fig. 6C) was similar to that of TH+ cells derived by the
SDIA method [24].
The survival of the BG02 hESC line under these conditions was
very limited as compared to that of the BG01V2 and BG03 cell
lines, and treatment of BG02-derived EBs with SPIE did not result
in expression of Msx1. We believe that there are differences in the
natureof various hESC lines,and that BG02 might require different
culture conditions, concentrations of factors, or additional extrinsic
signaling to differentiate to midbrain specific DA neurons. Indeed,
other studies have also reported a striking difference between neural
and DA induction of various hESC on mouse stromal cell lines
including PA6 and MS5 [3,6]. We have also observed (unpublished
data) that differences between BG01V2, BG02, and BG03 cells in
DA differentiation capacity are similar to those seen in the present
study when differentiated using SDIA or the method of Yan and
coworkers [2].
We also assessed the individual contributions of each of the five
factors and found that inclusion of IGFBP4 decreased the survival
of differentiating midbrain NPC, and that IGFBP4 was not
necessary for DA induction of hESC. IGF2 and PTN increased
the number of surviving colonies and TH+ neurons, respectively,
while SDF-1 and EFNB1 appeared to be required for specification
of DA neurons. Thus, the combination of the four factors SDF-1,
PTN, IGF2, and EFNB-1 termed ‘‘SPIE’’, can to some degree
mimic SDIA and produce a high yield of TH
+ neurons from hESC
in the presence of heparin.
Previously published Massively Parallel Signature Sequencing
(MPSS) analyses of hESC gene expression [30–32] were examined
to determine whether the SPIE receptors are expressed in hESC.
The IGF2 receptor (IGF2R) was expressed in undifferentiated
hESC. IGF2R expression was, however, negligible in hESC
differentiated as EBs for three weeks [31], or differentiated on PA6
cells. Expression of ephrin B1 receptors EPHB2 and EPHB4 was
also detected in undifferentiated hESC. Differentiation increased
expression of EPHB2 and EPHB3. The PTN receptor N-syndecan
(SDC3) was expressed in undifferentiated hESC as well as in hESC
differentiated on PA6 cells [30]. The SDF-1 receptor, CXCR4,
was undetectable or minimally expressed in undifferentiated
hESC, although it should be noted that the form of MPSS used
at that time failed to detect certain transcripts such as human TH
[30]. In a previous study by our group, gene expression profiling
by a focused human stem cell microarray showed expression of
CXCR4 in neurons generated from hESC by the SDIA method
[4]. In addition, previous focused gene expression array revealed
that IGFR1, IGFR2 and CXCR4 were expressed in undifferen-
tiated BG03 hESC [32]. A summary of the MPSS data can be
found at ftp://137.187.144.38/freed in the file entitled ‘‘MPSS
detection of SPIE receptors’’. The varying levels of expression of
these receptors suggests the possibility that the various components
of SPIE may be required at different stages of differentiation, a
possibility that we have not yet tested.
Induction of a midbrain DA phenotype by SPIE was confirmed
by the expression of midbrain specific markers including Lmx1b,
which is present during early specification of DA precursors [33],
Pitx3 [34] and En1 [35]. In addition, expression of receptors GFR1
[36] and c-RET [37] for glial cell line-derived neurotrophic factor,
which is a selective neurotrophic factor for midbrain DA neurons
[38], was upregulated by SPIE. Increased expression of the brain-
derived neurotrophic factor receptor, TrkB [39,40], and the SMO
receptor that is involved in SHH signaling [41], both of which are
highly expressed in midbrain DA neurons, was also detected in
SPIE-treated cultures. Furthermore, neurons differentiated from
hESC by SPIE exhibited electrical excitability, generated action
potentials, and spontaneous, miniature postsynaptic currents which
reflects establishment of functional synaptic networks.
It is interesting that there are two apparently unrelated
procedures for differentiating mesencephalic DA neurons from
hESC; techniques involving SDIA or SPIE, and the method of
Yan and coworkers [2]. Although both SPIE and the Yan et. al.
[2] techniques employ an EB formation phase, the treatment
protocols and growth factors which are employed are quite
different. In the present study, the morphology of SPIE-derived
cells was similar to that of cells differentiated by SDIA [24] and to
that of DA neurons differentiated by the procedure described by
Yan and coworkers [2]. Cells produced by the two methods are
also similar in that they express markers of mesencephalic DA
neurons. There may, however, be other or more subtle differences
between the cells derived by the two methods, which would
require additional studies to identify.
Growth and soluble factors produced by PA6 cells
Heparan-sulfate glycosaminoglycans such as heparin exist at the
cell surface and also in the extracellular matrix of many different
cell types are known to interact strongly with several growth
factors and modulate their biological activity during development
[42–44]. PTN is among the factors reported to have a high affinity
association with heparin-like molecules [45]. PTN has trophic
effects on DA neurons and increases the yield of TH+ neurons
differentiated from mouse ESC [46].
Serpin peptidase inhibitor, clade E, also known as SERPINE2, was
also identified among the heparin binding factors that were
differentially expressed in PA6-DA cells. SERPINE2 protein is highly
expressed in a variety of brain regions including the striatum during
nervous system development [47]. SERPINE2 was up-regulated, by a
Z-ratio of more than three, in PA6-DA cells in comparison with the
t r a n s f o r m e dP A 6 ,M S 5 ,a n dM M 5 5 Kc e l l s .H o w e v e r ,P A 6 - D Aa n d
MEF cells showed nearly equal expression of SERPINE2. This gene
product was not tested for neural or DA induction of hESC.
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cells was FGF-10, which is not considered to have a role in CNS
development. Nonetheless the introduction of FGF10 to chick
embryos up-regulated FGF8 expression in the ectoderm through
Wnt3a signaling and stimulated SHH expression in the posterior
mesoderm followed by outgrowth initiation of chick limb
structures [48,49]. These interactions of FGF10 with well-known
midbrain patterning cues suggests that this factor may be involved
in FGF8 and SHH signaling to enhance DA neurogenesis. Effects
of FGF10 on DA induction were also not tested.
The chemokine SDF-1 was originally identified in the immune
system and induces leukocyte chemotaxis [50]. In addition to its T-
cell chemotactic activity, SDF-1 is widely expressed in the nervous
system, and has been proposed to have a role in cerebellar
development [51,52]. SDF-1 also interacts with the Wnt pathway
in neural development [53] and mediates sonic hedgehog-induced
proliferation of cerebellar granule cells [54]. Up-regulation of
SDF-1 and its receptor CXCR4 was also observed during
differentiation of neural stem cells into more restricted precursors
[55]. Interestingly, a very recent study by Edman and colleagues
[54] demonstrated expression of two other a-chemokines, CXCL1
and CXCL6, in developing rodent ventral midbrain and suggested
that these factors have a regulatory role in the development of the
midbrain DA cell population.
IGFs and their carriers, IGF-binding proteins (IGFBPs) are
widely expressed throughout the CNS [56–58]. IGF2 has been
suggested to have neurotrophic effects, promoting survival and
differentiation of neuronal cells [59,60]. An indication of the
involvement of IGF2 in differentiation of mesencephalic neural
progenitor cells from hESC was recently obtained by our previous
MPSS analysis of gene expression in PSA-NCAM+ neuronal
precursors derived by SDIA. The IGF2 and H19 transcripts were
most abundant of the 11,912 distinct sequences detected. IGF2
expression was also found in laser-captured dopamine neurons
from human postmortem brain [30].
Transport and bioactivity of IGFs are regulated by six IGF-
binding proteins (IGFBP1-6) [61]. In addition to IGF2, we found
elevated expression of IGFBP4 in PA6-DA cells. Although there
are reports of elevation of IGFBP4 expression in rodents [62] and
neural precursors enriched from the human fetus during brain
development [63], the physiological role and signaling pathways of
IGFBP4 in neuronal differentiation are unknown. Co-localization
of IGF2 and IGFBP4 mRNAs as revealed by in situ hybridization
studies suggests a correlation between these two proteins in the
developing embryo [64]. We believe that involvement of IGFBP4
in the SDIA effect may be linked to regulation of IGF2 activity,
and in our study, IGFBP4 seemed to decrease the survival of
differentiating NPC.
Eph receptors and their ephrin ligands are essential for
migration and cell interactions of many cell types during
embryonic development [65,66]. B-class ephrins are transmem-
brane proteins which bind EphB receptors. Ephrin B1 acts both as
a ligand and as a receptor in a tissue-specific manner during
embryogenesis and is critically important in many biological
processes including axon guidance, neural crest migration [66,67].
The role of ephrin B1 in directing neuronal patterning in neural
stem cells has not been tested. However, another member of the
ephrin family, ephrin B2, and its receptor EphB1, have been found
in midbrain DA neuronal cells, where ephrin B2 induced cell loss
of substantia nigra, but not ventral tegmental DA neurons,
suggesting a role of this ligand-receptor pair in specification of the
nigrostriatal pathway [68]. In our previous study where the
contributions of cell surface and soluble factors to the SDIA effect
was examined, we found that PA6 cell surface factors promoted
cell survival and enhanced overall neurogenesis of hESC, rather
than providing lineage-specific instructions. Nevertheless, the
presence of cell surface factors enhanced the survival of hESC
during differentiation, which led to an increase in the overall yield
of DA neurons [23]. Also, DA differentiation in cultures of hESC
treated with factors secreted from PA6 cells plus heparin was
relatively less effective as compared to co-cultures with intact PA6
cells [23]. This discrepancy may be due to a progressive loss of
activity of the secreted signaling factors. Also, when PA6 cell
surfaces were tested for SDIA, paraformaldehyde was used to kill
the PA6 cells [23]. The fixation may have damaged membrane
bound factors or the extracellular domain of transmembrane
proteins such as ephrin B1, masking the potential role of these
molecules in DA differentiation. Thus, although ephrin B1 is not a
soluble secreted factor, we chose to examine its role in DA
neurogenesis.
The combination of four factors, currently termed SPIE, was
able to reproduce the effect of SDIA, however, the possibility that
additional signaling molecules would further enhance DA
induction from hESC cannot be excluded. Several other factors
were up-regulated, but to a significantly lesser degree. These
included members of the TGF-b family and factors involved in the
Wnt signaling pathway. It has been suggested that these factors
play a critical role in controlling neuronal fate and the
establishment of the DA phenotype [69,70]. It also may be that
additional factors would need to be added to SPIE to avoid the
requirement for the use of an EB induction phase, as was
employed in the current protocol.
It should also be noted that we detected significantly higher
levels of the soluble Wnt inhibitor secreted Frizzled-related protein
1(sFRP-1) in PA6-DA cells, which is suggested to have an
inhibitory effect on ventral midbrain neuronal development (Z-
ratio.14) than sFRP-2, which promotes DA neurogenesis and
maturation (Z-ratio.3) [71]. On the other hand, these soluble
factors might modulate the Wnt signaling pathway in a different
way during earlier stages of development, and thus could also play
a role in SDIA.
In summary, our findings constitute a simple system for the
induction and differentiation of hESC into DA neurons in a
culture system free of xenogenic cells or material. Future
investigations of the biological effect and mechanism of action of
these factors is likely to increase our understanding of the
molecular signaling that controls DA neuron differentiation from
hESC, ultimately contributing to the advancement of cellular
replacement strategies for treatment of PD. It should also be
mentioned that the risk of tumor formation arising from an
undifferentiated population of transplanted cells would need to be
assessed, and methods enhancing post-implantation cell survival
would need to be developed, before SPIE could be employed as a
transplantation strategy.
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